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ABSTRACT
Objectives: Vasodilation of the peripheral arteries
during reactive hyperaemia depends in part on release
of nitric oxide from endothelial cells. Previous studies
mainly employed a fingertip tonometric device to derive
pulse wave amplitude (PWA) and PWA hyperaemic
changes. An alternative approach is based on
photoplethysmography (PPG). We sought to evaluate
the correlates of digital PPG PWA hyperaemic responses
as a measure of peripheral vascular function.
Design: The Flemish Study on Environment, Genes
and Health Outcomes (FLEMENGHO) is a population-
based cohort study.
Setting: Respondents were examined at one centre in
northern Belgium.
Participants: For this analysis, our sample consisted
of 311 former participants (53.5% women; mean age
52.6 years; 43.1% hypertensive), who were examined
from January 2010 until March 2012 (response rate
85.1%).
Primary outcome measures: Using a fingertip PPG
device, we measured digital PWA at baseline and at 30 s
intervals for 4 min during reactive hyperaemia induced
by a 5 min forearm cuff occlusion. We performed
stepwise regression to identify correlates of the
hyperaemic response ratio for each 30 s interval after
cuff deflation.
Results: The maximal hyperaemic response was
detected in the 30–60 s interval. The explained variance
for the PPG PWA ratio ranged from 9.7% at 0–30 s
interval to 22.5% at 60–90 s time interval. The
hyperaemic response at each 30 s interval was
significantly higher in women compared with men
(p≤0.001). The PPG PWA changes at 0–90 s intervals
decreased with current smoking (p≤0.0007) and at
0–240 s intervals decreased with higher body mass
index (p≤0.035). These associations with sex, current
smoking and body mass index were mutually
independent.
Conclusions: Our study is the first to implement the
new PPG technique to measure digital PWA hyperaemic
changes in a general population. Hyperaemic response,
as measured by PPG, is inversely associated with
traditional cardiovascular risk factors such as male sex,
smoking and obesity.
INTRODUCTION
Endothelial dysfunction, a marker of reduced
nitric oxide (NO) bioavailability, contributes
to atherosclerosis and the pathogenesis of car-
diovascular disease.1 In humans, endothelial
dysfunction precedes the development of
clinically apparent atherosclerosis in indivi-
duals with cardiovascular risk factors.2
Vasodilation of the peripheral arteries during
reactive hyperaemia after ischaemia depends
in part on the release of NO from endothelial
cells in response to increased shear stress.3
This physiological response allows the non-
invasive assessment of endothelial vasomotor
function which can be measured based on
the flow-mediated dilation (FMD) of the bra-
chial artery4 or on the fingertip pulse ampli-
tude hyperaemic response.3 5 6 Previous
studies mainly applied fingertip peripheral
Strengths and limitations of this study
▪ Our study is the first to implement the new photo-
plethysmography (PPG) technique to measure
digital pulse amplitude hyperaemic changes in a
sample of a general population. A finger PPG is a
low-cost and operator-independent technique
compared with ultrasound in the assessment of
peripheral vascular function.
▪ Under strictly controlled conditions, we were able
to demonstrate a good intersession reproducibil-
ity of the hyperaemic response as measured by
the PPG technique.
▪ Our sample size was smaller compared with
other studies. On the other hand, the correlates
of hyperaemic response were as expected and
constitute an internal validation of the PPG tech-
nique in assessment of digital vascular function.
▪ Further research including clinical and prospect-
ive epidemiological studies is required to validate
the PPG technique for non-invasive assessment
of endothelial function and prediction of cardio-
vascular outcome, respectively.
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arterial tonometry (PAT) to derive pulse wave amplitude
(PWA) and, therefore, the pulse amplitude changes
during hyperaemia.3 5 6 Another approach to derive
information about the arterial pulse wave is based on
photoplethysmography (PPG).7 This optical technique
enables detecting blood volume changes in microvascular
beds during hyperaemia.7 We sought to evaluate the cor-
relates of digital PPG pulse amplitude hyperaemic
responses as a measure of peripheral arterial function in
a sample of a general population.
MATERIALS AND METHODS
Design and sample
From August 1985 until December 2005, we identified a
random population sample stratified by sex and age
from a geographically defined area in northern
Belgium.8 The seven municipalities gave listings of all
inhabitants sorted by address. Households, defined as
those who lived at the same address, were the sampling
unit. We numbered households consecutively, and gen-
erated a random-number list by using SAS random func-
tion. Households with a number matching the list were
invited. The initial participation rate was 78.0%.
The FLEMENGHO study is an ongoing longitudinal
population study and, therefore, the participants were
repeatedly visited at home and examined at a local
examination centre. From January 2010 until March
2012 a scheduled follow-up examination also included
measurement of digital vascular function with the PPG
technique. From 444 invited participants for this exam-
ination, we obtained informed written consent from 378
participants (response rate 85.1%). We excluded 43 par-
ticipants with cardiac dysrhythmias, such as atrial fibrilla-
tion, pacemaker and frequent extrasystole. Because the
PPG pulse amplitude was of insufficient quality to assess
vascular function (n=14) or because the hyperaemic test
was discontinued (n=10) we discarded a further 24 parti-
cipants. Thus, the number of participants statistically
analysed totaled 311.
Determination of PPG pulse amplitude
The participants refrained from smoking, heavy exercise
and drinking alcohol or caffeine-containing beverages
for at least 3 h before the test. No medication was
taken on the day of the examination. We studied digital
vascular function in an air-conditioned room at constant
temperature around 22°C. To attain a cardiovascular
steady-state before starting the test, the participants had
rested for at least 20 min in the supine position. Since
peripheral vasoconstriction is correlated with the sur-
rounding temperature, before the test, special care was
taken to keep the fingertips temperature around 35°C.
The blood pressure was the average of five auscultatory
readings, obtained with a standard sphygmomanometer.
The blood pressure measurement was performed on the
arm that served as control.
Digital pulse amplitude was measured with a PPG
device (FLOMEDI Company, Brussels) transmitting
infrared light at a wavelength of 940 nm and positioned
on the tip of each index finger. Digital output from the
PPG device was recorded through an analogue-to-digital
converter (10 bit, sampling frequency 250 Hz). We
expressed the amplitude of the PPG PWA signal in arbi-
trary units. To determine the amplitude changes of the
digital pulse curve in response to hyperaemia, we used a
protocol as described by Hamburg et al.6 As shown in
figure 1C,D, baseline PPG pulse amplitude was regis-
tered at each of the two index fingertips for at least
5 min to ensure a stable baseline PPG signal. For the
analysis, we used PPG pulse amplitude that was mea-
sured for last 2 min 20 s. Next, arterial flow was inter-
rupted for 5 min by an inflatable cuff placed on the
proximal forearm with an occlusion pressure of 200–
220 mm Hg (around 50 mm Hg above the participant’s
systolic pressure). Complete cessation of blood flow to
the hand is verified by the absence of a PPG signal from
the occluded arm. After cuff deflation, we analysed the
PPG pulse amplitude at both fingers using a compu-
terised, automated algorithm (FLOMEDI Company,
Brussels) that provided the averaged pulse amplitude for
each 30 s interval up to 4 min (see the PPG pulse track-
ing in figure 1).
For each 30 s interval, the response of the PPG PWA
to hyperaemia was calculated from the hyperaemic
fingertip as the ratio of the postdeflation PPG pulse
amplitude to the baseline amplitude (PAht/PAh0, where
PA is the pulse amplitude, h is the hyperaemic finger,
t is time interval and 0 is baseline). To obtain the PPG
pulse amplitude ratio we divided PAht/PAh0 ratio by the
corresponding ratio at the control hand (PAct/PAc0,
where c is the control finger).
To determine the intersession reproducibility of the
hyperaemic response, we analysed PPG ratios measured
on two different occasions in five participants. We deter-
mined the absolute and relative biases of the averaged
PPG pulse amplitude ratios per each 30 s time interval
between the two sessions as well as 95% limits of agree-
ment between sessions. Absolute and relative biases
between the two sessions were calculated according to
Bland and Altman’s method as (x1−x2) versus averaged
and (100(x1−x2)/averaged) versus averaged, respect-
ively. The absolute and relative biases of the averaged
PPG pulse amplitude ratios at each time interval
between the two sessions were 0.062 (95% CI –0.10 to
0.23) and 3.29% (95% CI –8.8% to 15.4%), respectively.
Other measurements
At the examination centre, trained study nurses adminis-
tered a questionnaire to collect detailed information on
each participant’s medical history, smoking and drinking
habits, and intake of medications. Hypertension was a
blood pressure of at least 140 mm Hg systolic or
90 mm Hg diastolic (average of five consecutive ausculta-
tory readings at the examination centre) or the use of
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antihypertensive drugs. Body mass index was weight in
kilograms divided by the square of height in metres.
Overweight was a body mass index between 25 and
30 kg/m². Obesity was a body mass index of 30 kg/m2 or
higher.
Statistical methods
For database management and statistical analysis, we
used SAS software, V.9.1 (SAS Institute, Cary, North
Carolina, USA). The central tendency and the spread of
the data are reported as mean±SD. Departure from nor-
mality was evaluated by Shapiro-Wilk’s statistic and skew-
ness by computation of the coefficient of skewness, that
is, the third moment about the mean divided by the
cube of the SD. We compared means and proportions
by means of a sample t test and by the χ2 test, respect-
ively. Significance was p<0.05 on two-sided test.
We performed single and stepwise multiple regression
to assess the independent correlations of the PPG pulse
amplitude ratio during each 30 s interval with sex, age,
systolic and diastolic blood pressures, heart rate, body
mass index, current smoking, total cholesterol, low-
density lipoprotein (LDL) cholesterol, haematocrit,
blood glucose, antihypertensive and lipid-lowering drug
treatment and history of ischaemic heart disease. We set
the p values for variables to enter and to stay in the
regression models at 0.10.
RESULTS
Characteristics of participants and PPG pulse amplitude
The participants included 154 (53.5%) women and 134
(43.1%) patients with hypertension of whom 78 (25.1%)
were on antihypertensive drug treatment. Table 1 shows
the clinical characteristics and PPG pulse amplitude
measures of the study participants by sex. In this cohort,
women had lower systolic and diastolic blood pressure
and higher heart rate than men, less often reported
alcohol consumption and had no history of ischaemic
heart disease. The geometric means of the baseline PPG
amplitude were 7.3 (5–95% centiles: 2.7–25.9) and 9.3
(5–95% centiles: 3.9–25.3) at the hyperaemic and
control finger, respectively. We observed a high correl-
ation between values of the baseline PPG amplitude
Figure 1 (A) Image showing a system incorporating two photoplethysmography (PPG) devices transmitting infrared light,
analogue-to-digital converter and forearm pressure cuff. (B) Showing the position of cuff and two PPG devices during the test.
(C and D) showing recorded pulse amplitude tracing. In the arm undergoing hyperaemia (C, top tracing; and D), baseline
amplitude is recorded. During cuff inflation, flow is occluded and restores after cuff release (hyperaemic period). In the
contralateral control finger (C, bottom tracing), flow continues throughout, and pulse amplitude undergoes minimal changes.
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Table 1 Characteristics of participants
Clinical measurements PPG pulse amplitude measures
Characteristics Women (n=154) Men (n=157) p Value Characteristics Women (n=154) Men (n=156) p Value
Anthropometrics PPG ratio
Age, years 53.51±12.2 51.8±14.5 0.26 Time intervals (s)
Body mass index, kg/m2 26.3±4.0 27.3±3.7 0.03 0–30 1.43 (0.87 to 2.02) 1.27 (0.83 to 1.84) 0.002
Systolic pressure, mm Hg 125.5±15.4 131.4±14.3 0.0006 30–60 1.93 (1.08 to 2.86) 1.46 (1.00 to 2.13) <0.0001
Diastolic pressure, mm Hg 80.4±8.0 84.5±9.5 <0.0001 60–90 1.84 (1.10 to 2.50) 1.37 (0.97 to 1.93) <0.0001
Heart rate, bpm 66.5±10.2 62.4±9.9 0.0003 90–120 1.64 (1.09 to 2.16) 1.27 (0.93 to 1.79) <0.0001
Questionnaire data 120–150 1.49 (1.06 to 2.01) 1.20 (0.92 to 1.59) <0.0001
Current smoking, n (%) 28 (18.2) 18 (11.5) 0.10 150–180 1.38 (1.00 to 1.84) 1.16 (0.89 to 1.46) <0.0001
Alcohol, n (%) 39 (25.3) 94 (59.9) <0.0001 180–210 1.30 (0.98 to 1.65) 1.14 (0.87 to 1.43) <0.0001
Diabetes, n (%) 5 (3.3) 4 (2.6) 0.72 210–240 1.24 (0.95 to 1.65) 1.11 (0.87 to 1.33) <0.0001
Treated for hypertension, n (%) 38 (24.7) 40 (25.5) 0.87
β-blockers, n (%) 18 (11.7) 23 (14.7) 0.44
ACE or ARB, n (%) 12 (7.8) 15 (9.6) 0.58
Diuretics or CCB, n (%) 22 (14.3) 19 (12.1) 0.57
History of IHD, n (%) 0 (0) 7 (4.5) 0.008
Total cholesterol, mmol/L 5.2±1.00 5.0±0.96 0.037
Lipid lowering agents, n (%) 10 (6.5) 8 (5.1) 0.60
Values are mean (±SD), mean (10–90%) or number of participants (%).
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blockers; CCB, calcium channel blockers; IHD, ischaemic heart disease; PPG, photoplethysmography.
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recorded at both fingers (r=0.89, p<0.0001). As shown in
figure 2, after forearm cuff deflation, the ratio of the
PPG pulse amplitude to baseline rose rapidly in the
hyperaemic fingertip, with maximal response occurring
in the 30–60 s interval, whereas the changes of PPG
amplitude in the control finger were minimal. Table 1
lists the mean values of the postdeflation PPG pulse
amplitude ratio at each 30 s interval by sex. The hyper-
aemic response at each 30 s interval was significantly
higher in women compared with men (table 1). In both
women and men, the maximal hyperaemic response was
detected in the 30–60 s interval.
Determinants of PPG pulse amplitude ratio
We performed stepwise regression to assess the inde-
pendent correlations of the hyperaemic response for
each 30 s interval after cuff deflation with sex, age, sys-
tolic and diastolic blood pressures, heart rate, body mass
index, current smoking, total cholesterol, LDL choles-
terol, haematocrit, blood glucose, antihypertensive and
lipid-lowering drug treatment, and history of ischaemic
heart disease. With age forced in the models, the
explained variance for the PPG pulse amplitude ratio
ranged from 9.7% at 0–30 s interval to 22.5% at 60–90 s
time interval (table 2). The PPG PWA changes through-
out 0–240 s intervals significantly decreased with male
sex (p≤0.0004) and with body mass index (p≤0.017).
The hyperaemic response at 0–90 s intervals decreased
with current smoking (p≤0.0007). These associations
with sex, body mass index and current smoking were
mutually independent. In addition, the PPG pulse amp-
litude ratio at 30–60 s interval decreased with total chol-
esterol, but this association only reached borderline
significance (p=0.045; table 2). Blood glucose was also
selected as an independent determinant of the PPG
ratio (table 2), but overall impact of this covariable is
relatively small (explained about 1.5% of total variabil-
ity). Moreover, blood glucose was not a significant deter-
minant of the maximal peak of hyperaemic response
which occurs at 30–60 s and 60–90 s intervals.
Figure 3 illustrates the hyperaemic responses by the
smoking status while adjusted for important covariables.
The maximal hyperaemic response in the 30–60 s inter-
val was significantly lower in current smokers compared
with non-smokers (1.37 vs 1.76; p<0.0001). Figure 4
shows the adjusted PPG pulse amplitude hyperaemic
responses in participants, divided into three categories
according to their body mass index. In overweight
(n=134; 1.51±0.060) and obese (n=64; 1.44±0.082) parti-
cipants the maximal hyperaemic response was signifi-
cantly lower compared with lean participants (n=113;
1.71±0.064).
DISCUSSION
In our cohort recruited from a population study, we eval-
uated the relationship between PPG pulse amplitude
hyperaemic response, a non-invasive measure of periph-
eral microcirculation and cardiovascular risk factors. We
observed a time-dependent increase in digital PPG pulse
amplitude that peaked in the 30–60 s interval after
induction of reactive hyperaemia. In keeping with the
literature,6 9–11 we found that PPG pulse amplitude
hyperaemic response was higher in women than in men
and in non-smokers than smokers. Moreover, digital
vasodilator function as measured by the PPG technique
inversely correlated with body mass index.
Endothelial function is often estimated non-invasively
by vascular reactivity tests. Several methods are available
to study endothelial function in the peripheral
Figure 2 Photoplethysmography
(PPG) pulse amplitude response
for the hyperaemic and control
finger in women (circles) and men
(squares). Women had more
pronounced responses than men.
Symbols are means, dashed line
—95% CI.
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Table 2 Correlates of PPG ratios selected by stepwise regression
Parameters
PPG ratio
Time intervals (s)
0–30 30–60 60–90 90–120 120–150 150–180 180–210 210–240
Regression statistic
Model R2 (%) 9.7 21.4 22.5 19.8 19.2 16.3 13.2 12.2
Age (+10 years)*
β±SE 0.014±0.020
p=0.45
−0.0007±0.028
p=0.98
0.005±0.025
p=0.85
0.004±0.019
p=0.85
0.007±0.017
p=0.68
−0.0008±0.014
p=0.95
0.004±0.012
p=0.72
0.002±0.011
p=0.91
Partial r2 (%) 0.02 0 0.01 0.04 0.06 0 0.04 0.01
Female
β±SE 0.16±0.05
p=0.0004
0.49±0.68
p<0.0001
0.46±0.061
p<0.0001
0.35±0.050
p<0.0001
0.26±0.041
p<0.0001
0.20±0.035
p<0.0001
0.14±0.031
p<0.0001
0.12±0.03
p<0.0001
Partial r2 (%) 3.9 13.6 16.0 15.1 13.5 12 7.7 6.1
Current smoking (0,1)
β±SE −0.30±0.07
p=0.0004
−0.39±0.09
p<0.0001
−0.29±0.085
p=0.0007
– – – – –
Partial r2 (%) 4.0 3.7 3.1 – – – – –
Body mass index (+1 kg/m²)
β±SE −0.014±0.007
p=0.017
−0.027±0.009
p=0.003
−0.032±0.008
p<0.0001
−0.025±0.007
p<0.0001
−0.022±0.005
p<0.0001
−0.018±0.005
p<0.0001
−0.015±0.004
p=0.0002
−0.013±0.004
p=0.0008
Partial r2 (%) 1.7 3.0 3.4 3.4 4.5 4.5 4.1 3.5
Total cholesterol (+1 mmol/L)
β±SE – −0.068±0.034
p=0.045
– – – – – –
Partial r2 (%) – 1.1 – – – – – –
Blood glucose (+1 mmol/L)
β±SE 0.10±0.04
p=0.013
– – 0.07±0.04
p=0.026
0.06±0.03
p=0.034
– 0.05±0.02
p=0.027
0.06±0.02
p=0.006
Partial r2 (%) 1.9 – – 1.3 1.2 – 1.4 2.2
Values are mutually adjusted partial regression coefficients ±SE. *Age was forced into all models. The covariables considered in stepwise models included sex, systolic and diastolic blood
pressures, heart rate, body mass index, current smoking, total cholesterol, LDL cholesterol, haematocrit, blood glucose, antihypertensive and lipid-lowering drug treatment, and history of
ischaemic heart disease.
LDL, low-density lipoprotein; PPG, photoplethysmography.
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macrocirculation (conduit arteries) and microcirculation
(resistance arteries and arterioles).2 12 Measurement of
the brachial artery diameter before and after 5 min of
occlusion of the arterial flow to the forearm is the most
widely used test to assess endothelium-dependent vaso-
dilation.4 13 14 The change in arterial diameter gives a
measure of FMD. This technique, however, is operator
dependent, is costly and requires a long postprocessing
time. Measurement of microcirculatory reactive hyper-
aemia can be assessed by digital pulse amplitude mea-
sured by applanation tonometry5 6 or PPG.15 16 Lund17
described the potential of the PPG technique for the
assessment of vasodilation by using this technique to
measure haemodynamic response to nitroglycerin.
Moreover, Theunissen et al18 observed in divers an
increase in circulating NO after successive breath-hold
dives. This increase in circulating NO level was asso-
ciated with higher hyperaemic response measured using
the same PPG device as in our study.
Both techniques for assessment of digital vascular func-
tion are non-operator dependent, and the equipment is
an order of magnitude less expensive than for ultrasonog-
raphy. However, the tonometry method might be more
expensive as compared to the PPG technique because of
additional costs associated with changeable plethysmo-
graphic probes. Furthermore, the digital tonometry pro-
cedure is more complicated and less comfortable for
patients because it requires attachment of a pneumoelec-
trical tube to an additional pneumatic digital cuff which
should be constantly inflated during the test.
We observed similar digital PPG pulse amplitude
changes during the hyperaemic response compared with
Figure 3 Photoplethysmography
(PPG) ratio of pulse amplitude for
each 30 s time interval after cuff
deflation to the baseline pulse
amplitude divided by the
corresponding ratio in the control
finger in smokers and
non-smokers participants.
Smokers had significantly lower
response throughout the 0–120 s
postdeflation intervals. Symbols
are means and SE. Models are
adjusted for sex, age, body mass
index, total cholesterol and blood
glucose. ***p<0.001 versus
non-smokers.
Figure 4 Photoplethysmography
(PPG) ratio of pulse amplitude for
each 30 s time interval after cuff
deflation to the baseline pulse
amplitude divided by the
corresponding ratio in the control
finger in participants with normal
body mass index (BMI), overweight
(25 kg/m2≤BMI<30 kg/m2) and
obesity (BMI≥30 kg/m2). Symbols
are means and SE. Models are
adjusted for sex, age, smoking,
total cholesterol and blood
glucose. *p<0.05, **p<0.01,
***p<0.001 versus lean
participants. †p<0.05, ††p<0.01,
versus lean participants.
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results from studies using the finger applanation
tonomtery-based method.6 10 11 In the Framingham
study,6 10 similar to our study, the ratio of the digital
pulse amplitude to baseline rose rapidly in the hyper-
aemic fingertip after forearm cuff deflation, and then
slowly decreased towards baseline. However, we detected
the maximal hyperaemic response in the 30–60 s inter-
val, whereas in the Framingham study the pressure amp-
litude ratio was highest in the 60–90 s interval. The
difference in the time of maximal hyperaemic response
between the Framingham study and our report might be
related to the fact that finger PAT measures pressure
changes while PPG measures changes of the relative
amount of blood volume.
We observed the relations between the hyperaemic
PPG pulse amplitude response and cardiovascular risk
factors. In our current study and in other community-
based studies,6 10 11 men had a less pronounced
hyperaemic response than women, which is probably
in part attributable to physiological differences in
vessel diameter and wall thickness between the sexes.
In line with other studies,6 10 11 which used the PAT
technique to evaluate digital vascular function, we
demonstrated a significant inverse association between
PPG amplitude changes and smoking, obesity and
total cholesterol. The mechanism underlying these
associations might be related to the fact that exposure
to cigarette smoke and metabolic risk factors causes
impairment of NO production and an increase of oxi-
dative stress and proinflammatory reaction that leads
to endothelial dysfunction and atherosclerosis.19 We
also tested the influences of antihypertensive and anti-
hyperlipidaemic treatment on the hyperaemic PPG
pulse amplitude response, which were not significant
(results not shown). The observed association between
the PPG PWA ratio and blood glucose during some
time intervals might be related to the optic technique
which we used in our study.
Similar to other studies, in which finger applanation
tonometry was used to assess the digital vascular func-
tion,10 we did not observe a significant relation between
hyperaemic PPG pulse amplitude changes and age. On
the other hand, previous studies reported lower hyper-
aemic response as assessed by FMD with advancing
age.13 14 Differences in the age-related hyperaemic
responses between microcirculatory and macrocircula-
tory reactivity might explain these divergent findings.9
Moreover, recent studies demonstrated that brachial and
digital measures of vascular function were uncorrelated
with each other.10 20 It was suggested that FMD and PAT
provide distinct information regarding vascular function
in conduit versus smaller digital vessels. In our study we
also did not observe the difference in hyperaemic
response between patients with hypertension and
normotensive participants. Similar finding was observed
in another epidemiological study10 that used applana-
tion tonometry in assessing microvascular function. We
could speculate that the PPG reactive hyperaemia index
(microvasculature) is more sensitive to metabolic factors,
especially body mass index, smoking and total choles-
terol and less sensitive to systemic haemodynamic factors
such as high blood pressure.
The present study must be interpreted within the
context of its potential limitations and strengths. First,
PPG pulse amplitude registration is prone to measure-
ment error due to higher variability in comparisons with
the FMD technique.21 On the other hand, assessment of
the hyperaemic PPG PWA changes requires little train-
ing and is operator independent. Moreover, under
strictly controlled conditions, we were able to demon-
strate a good intersession reproducibility of the hyper-
aemic response as measured by the PPG techniques.
Second, placing the occlusion cuff above the site of
hyperaemic response measurement might evoke a dila-
tory response that is related in part to ischaemia and,
therefore, is not entirely mediated by NO. Moreover, the
sex difference in the hyperaemic response observed in
our study might be in part attributable to physiological
differences in vessel diameter (allometric differences)
and, therefore, could not also entirely be explained by
low NO realise in men. Further studies should account
for the differential response to hyperaemia between
men and women. Third, our sample size was smaller
compared with other studies.10 11 On the other hand,
the correlates of hyperaemic response were as expected
and constitute an internal validation of the PPG techni-
ques in assessment of digital vascular function. Fourth,
as shown in table 2, in our study, we could explain only
around 20% of variability of the PPG PWA ratios by trad-
itional cardiovascular risk factors. The remaining vari-
ability might be influenced by genetic factors,
inflammatory processes or other confounders that we
did not consider in our study. Moreover, in our opinion,
it is important to demonstrate in prospective studies that
the hyperaemic response as assessed by the PPG tech-
nique might be an independent predictor of cardiovas-
cular events.
In conclusion, our study is the first to implement the
PPG technique to measure digital pulse amplitude
hyperaemic changes in a sample of a general popula-
tion. We demonstrated that measurement of the hyper-
aemic response by the PPG technique might be a useful
tool in the detection of peripheral microvascular dys-
function associated with smoking and obesity, while
accounting for the differential hyperaemic response
between men and women. Further research including
clinical and prospective epidemiological studies is
required to validate the PPG technique for non-invasive
assessment of endothelial function and prediction of
cardiovascular outcome, respectively.
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